dextroamphetamine has been researched along with gamma-linolenic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, LE; Kleykamp, D; Kontras, SB; Taylor, WA; Tobin, K; Votolato, NA | 1 |
| Arnold, LE; Pinkham, SM; Votolato, N | 1 |
2 trial(s) available for dextroamphetamine and gamma-linolenic acid
| Article | Year |
|---|---|
Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Dextroamphetamine; Double-Blind Method; gamma-Linolenic Acid; Humans; Linolenic Acids; Male; Random Allocation | 1989 |
Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder?
Topics: Antioxidants; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Fatty Acids, Essential; gamma-Linolenic Acid; Humans; Linoleic Acids; Male; Nutritional Status; Oenothera biennis; Plant Oils; Zinc | 2000 |